|
⚲
|
| Numira Biosciences Inc | |
|---|---|
| Firm | |
| Fund # | |
| CIK # | 0001454392 |
| Sale | 2009-01-09 ($3.3 M Offered, $3.3 M Sold) |
| Fund | |
| Phone | 9495670920 |
| Address | 2151 Michelson Drive, Suite 250 Irvine, 92612 |
| Source | [EDGAR] |
| Fund AUM and Sold ($M) |
|---|
| Fund Details | |
|---|---|
| Director | |
| Custodian | |
| Auditor | |
| Marketer | |
| Broker | |
| Jurisdiction |
| Directors | 2011 - 2025 |
|---|---|
| Dinesh Patel | |
| Paul Deridder | |
| Anthony Purchio | |
| Paul Grint | |
| Michael Beeuwsaert | |
| David Weinstein |
| Comparable Firms | State | AUM ($B) |
|---|---|---|
|
Kruse Capital Fund D-I, LP
✚
|
0.0 | |
|
Gavekal Asian Value Fund
✚
|
0.0 | |
|
Leeward, Inc.
✚
|
0.0 | |
|
L-55 Hawthorne REIT, LLC
✚
|
0.0 | |
|
LAB Fund I, a series of Medici VC II, LP
✚
|
0.0 | |
|
Kutyna Donald J
✚
|
0.0 | |
|
Blockchain Technology Partners, LP
✚
|
0.0 | |
|
Gateway Seed II LP
✚
|
0.0 | |
|
Gato Investments LP
✚
|
0.0 | |
|
Gavekal Global Asset Allocation UCITS Fund
✚
|
0.0 |